A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations

Tetracycline-based matrix metalloproteinase- (MMP-) inhibitors are currently approved for two inflammatory diseases, periodontitis and rosacea. The current study addresses the therapeutic potential of a novel pleiotropic MMP-inhibitor not based on an antibiotic. To induce experimental periodontitis,...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Elburki, Muna S., Rossa, Carlos, Guimaraes, Morgana R., Goodenough, Mark, Lee, Hsi-Ming, Curylofo, Fabiana A., Zhang, Yu, Johnson, Francis, Golub, Lorne M.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101223/
https://ncbi.nlm.nih.gov/pubmed/25104884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/959471
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires